Australia TGA ARTG recordInfusion administration set, insulin pump
Australia TGA ARTG Registered Device · Roche Diabetes Care Australia Pty Ltd · Roche Diabetes Care GmbH · Class IIb · Started August 28, 2018
Good Name: Roche Diabetes Care Australia Pty Ltd - Infusion administration set, insulin pump
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 28, 2018
- Effective Date
- August 28, 2018
- Country
- Germany
- Address
- Sandhofer strasse 116, Mannheim, 68305
The Accu-Chek Solo Reservoir is a sterile part of the micropump used as a container for holding the insulin that the micropump delivers to the body.
Access comprehensive regulatory information for Infusion administration set, insulin pump in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by Roche Diabetes Care GmbH in Germany. The device registration started on August 28, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.